Abstract
This study aims to propose a new method for derivatizing fatty acids (FAs) from human milk (HM), eliminating the lipid extraction step, and simplifying the preparation for gas chromatography with a flame ionization detection (GC-FID) analysis to quantify the FAs. The Design Expert software optimized the reaction times, concentrations, and sample amount. The proposed method (PM) was validated for lyophilized HM and results for the figures of merit for precision in relative standard deviation (RSD) (RSDintra-day 1.34-4.03% and RSDinter day 2.08 5.16%), accuracy (99.87-102.16%), and robustness are within a linear range of 3 to 38% lipids in HM samples. The atmospheric solids analysis probe tandem mass spectrometry (ASAP-MS/MS) technique confirmed the efficiency of PM by expressing the molecular composition of triacylglycerol formed by FAs from the GC-FID technique. The PM requires a small sample size and conducts derivatization directly in the sample matrix, minimizing extraction errors.
Keywords: analytical parameters; lipids; atmospheric-pressure solids analysis probe; ultrasound
Introduction
The World Health Organization and pediatricians recommend human milk (HM) as the exclusive source of nutrition during the first six months of the life of neonate.1 The composition of HM is rich in essential compounds, including carbohydrates, proteins, and lipids, that are important for the development of the immunologic and cognitive systems of the neonate.2-4
Lipids have structural and regulatory functions and are the major source of energy in HM,5 in which fatty acids (FAs) are essential for the development of the central nervous system in the first two years of life, favoring the action of digestive lipases, increasing anandamide levels, and producing analgesic effects.5-7 Besides, FAs are important for the immune, cognitive, visual, and motor development of newborns.8
The HM consumed by neonates differs in composition and volume. When exploring relationships between maternal impact and infant outcomes, it is important to consider the overall profile of the HM FAs and the intake of each HM component.9 So, quantifying the FAs present in HM is an important aspect of the HM study. The analysis of FAs in HM by gas chromatography with a flame ionization detector (GC FID) is extensively reported in the literature.3,10,11 Usually, this analysis requires three steps: lipid extraction; derivatization to methyl esters by derivatization reactions; and quantification by GC-FID.12
The standard lipid extraction method used for the analysis of FAs in HM was proposed by Folch et al.13 However, this methodology needs long extraction times to provide acceptable extraction efficiency, which leads to a laborious procedure and requires large volumes of organic solvents (chloroform and methanol in a 2:1 v/v ratio). In addition, extensive sample manipulation, including agitation, phase separation, filtration, and evaporation, increases the probability of experimental errors.12,13 After extraction, FAs need to be derivatized to fatty acid methyl esters (FAMEs),7 which are then detected by GC-FID, due to their volatile and thermal stability characteristics.14
Direct methylation has been gaining popularity over the last few years as a derivatization methodology for the analysis of FA composition in different samples, such as bovine fat, infant formulas, and fermented milk samples.15-18 The method is simpler and faster than traditional methods, because lipid extraction and derivatization occur simultaneously in a oneor two-steps (base-catalyzed hydrolysis, followed by acid hydrolysis). In addition, direct methylation requires a low amount of sample and solvents and is less susceptible to experimental errors due to decreased sample manipulation.15-20
However, to the best of our knowledge, no study has proposed a method of direct methylation for analysis of FA composition in lyophilized human milk (HMlyo). Therefore, this study proposes a novel procedure of derivatization to determine the FA composition in mature HMlyo, without the need for previous lipid extraction, using low quantities of samples and solvents. Moreover, the proposed method was also applied to samples of HMlyo and liquid HM (HMliq) at different lactation stages (colostrum, transitional and mature). The HMlyo was chosen due to its advantages for the human milk bank (HMB) presented in previous studies,6 including the increase of the shelf-life of the product, stopping the microbial growth, and retarding the lipid oxidation process. The use of the lyophilization process by the HMB can be a good alternative to prolong the shelf-life of human milk and facilitate its transport and storage.
Experimental
Reagents, solvents and standards
Potassium hydroxide (KOH), hydrochloric acid (HCl), chloroform, n-heptane, and methanol (MeOH) (all analytical grade) were acquired from Labsynth (Diadema, Brazil). Reference standards of methyl tricosanoate (23:0; ≥ 99%), tritridecanoin (TAG 13:0; ≥ 99%), FAME Mix, C4-C24 unsaturated (≥ 97%) were purchased from Sigma Aldrich (São Paulo, Brazil).
HM samples
The present study was approved by the Research Ethics Committee local, under number 2.797.476/2018, of the Universidade Estadual de Maringá (UEM, Maringá, Brazil). HM samples in different lactation phases (colostrum, transitional, and mature) were collected from 20 distinct donors, following a specific protocol for HMB of the Hospital Universitário de Maringá (Maringá, Brazil), and stored at 4 °C in a domestic refrigerator. Samples were homogenized, grouped into pools (2 L) according to each lactation phase, and stored at -32 °C in a vertical series MFV/UFV ultra-freezer (Terroni Scientific equipment, Pauliceia, Brazil) until analysis.
Lyophilization
The 960 mL pool of colostrum, transitional, and mature HM were subjected to the lyophilization process. Samples (80 mL) were lyophilized using an SLH-50 lyophilizer (Terroni Scientific Equipments, São Carlos, Brazil) at -55 °C and 0.05 mmHg for 72 h. The operating conditions used were recommended by the manufacturer. Only mature HMlyo (HMlyoM) was utilized for the development of the proposed method. The HMlyo from the other lactation phases, colostrum (HMlyoC) and transitional (HMlyoT), were utilized to verify the applicability of the proposed method (PM, see sub-section “Proposed method (PM) of lipid extraction and derivatization”).
Traditional method (TM) of lipid extraction and derivation
Lipid extraction was performed according to Folch et al.13 Approximately 10 g of samples were added into a beaker. Then 200.0 mL of chloroform:methanol mixture (2:1, v/v) was added, and the solution was stirred vigorously for 3 min. The resulting solution was filtered in a Büchner funnel through a quantitative filter paper. The solution obtained was transferred to a separation funnel and left undisturbed for 24 h to allow phase separation. The lower part of the separation containing chloroform and lipids was transferred to a 250 mL pre-weighed flat bottom flask, and the solvent was evaporated in a rotary evaporator (Prismalab, Rio de Janeiro, Brazil).
Derivatization reactions of the FAs were performed according to the International Organization for Standardization ISO 12966:2/2017.21 Lipid samples (100.0000 mg) were weighed in a tube, followed by the addition of 500 µL standard 23:0 solution (1.0 mg mL-1 in n-heptane m/v) and 2.0 mL n-heptane were added. The solution was stirred in a vortex for 2 min (Forlab Express, Higienópolis, Brazil). Next, 3.0 mL KOH/MeOH (2 mol L-1) was added and stirred in a vortex for 3 min. The resulting solution was left undisturbed for 24 h to allow phase separation at 4 °C in a domestic refrigerator. The superior portion (organic portion) was collected for further GC-FID analysis.
Experimental design
A rotational central composite design was generated by Design Expert® 7 software22 to model a second-order response surface, it provides error prediction uniformity.23 For this, five independent variables (concentrations of acid and base, reaction times of acid and base, and sample mass) at five levels were to associate their individual effects and interactional influences on the dependent variable (sum of FA). The -α and +α levels for acid and base reactions time, acid and base concentration, and sample mass were: 5.00 and 25.00 min, 0.38 and 1.88 mol L-1, and 30.0000 and 310.0000 mg, respectively. The axial points (± α) provided by the rotational system (k < 5) were ± 1.4142 and were applied to calculate the quadratic terms, as presented in Table S1 (in the Supplementary Information (SI) section). The design comprises 32 experiments, with five replications at the center point (Table 1). The temperature of the experiments was set at 25 °C.
Central composite rotational experimental design and sum of FAs obtained for lyophilized mature human milk by GC-FID
Proposed method (PM) of lipid extraction and derivatization
In a glass tube containing 100.0000 mg of HMlyoM, internal standard solutions 23:0 (500 µL) and TAG 13:0 (2.0 mL) (both prepared at 1.0 mg mL-1 in n-heptane m/v) were added along with 2.0 mL of KOH/MeOH (using different concentrations according to the experimental design and presented in Table 1).
Then, the solution was stirred in a vortex for 2 min and placed into an ultrasonic bath (Eco-Sonics Q 5.9/25, Unique, São Paulo, Brazil) at different reaction times as determined by experimental design (Table 1), with 165 W potency, 25 kHz frequency, and 25 °C temperature. After alkaline reaction time, 2.0 mL of HCl/MeOH (at different concentrations) was added to the mixture. The solution was stirred in a vortex for 2 min and placed into an ultrasonic bath at different reaction times (Table 1) under the same conditions employed for the alkaline reaction. Then, 1.0 mL n-heptane was added to the mixture, and the tube was stirred for 30 s in a vortex and centrifuged under 2000 rpm for 1 min. The solution was stored at 4 °C to allow phase separation for 24 h in a domestic refrigerator. The superior portion (organic portion) was collected for further GC-FID and atmospheric pressure solid analysis probe (ASAP) analysis.
Gas chromatography analysis
Chromatographic analyses were carried out in a Shimadzu GC-2010 Plus (Kyoto, Japan) equipped with a flame ionization detector (FID), split/splitless injector, and a fused silica capillary column CP-7420 (Select FAME, 100 m length, 0.25 mm i.d., and 0.25 μm film thickness of cyanopropyl as stationary phase). The gas flows used were 1.4 mL min-1 for carrier gas (H2), 30.0 mL min-1 for make-up gas (N2), and in the FID 30.0 and 300.0 mL min 1 for H2 and synthetic air, respectively. Samples were injected in split mode (1:40) and an injection volume of 2 μL. The column temperature was raised to 65 °C for 4 min, then heated to 185 °C at 16 °C min-1. After 12 min, the temperature was raised to 235 °C at 20 °C min-1 and maintained for 9 min, totaling an analysis time of 35 min. The injector and detector temperatures were 230 and 250 °C, respectively. FAMEs were identified by comparing the retention times of the compounds of the samples with those of the analytical standard (FAME Mix, C4-C24). The Lab Solutions software was used to determine peak areas. The analysis was performed in triplicate. Theoretical FID correction factor was used to obtain FA concentration values (mg g-1 of sample) carried out by comparing the retention times of the compounds in the samples with those of the analytical standard FAME Mix, C4-C24, and they where quantified using the internal standard 23:0 according to Visentainer et al.,24 as demonstrated by equation 1:
where Mx: concentration of the fatty acid (mg g-1 of sample); AX: peak area of the fatty acids; Ap: peak area of the internal standard (23:0); Mp: mass of internal standard (23:0) added to the sample (mg); MA: mass of sample (g); FCT: theoretical correction factor of the flame ionization detector (FID); FCEA: conversion factor from methyl ester to fatty acid.
In addition, the transesterification performance (%) of the PM was determined on the recovery of the TAG 13:0 internal standard based on the equation 2:25
where m23:0: mass of 23:0 internal standard added to the solution (mg); A13:0: peak area of TAG 13:0 internal standard in the chromatogram; R13:0: response factor of TAG 13:0 compared to 23:0; S13:0 (TAG): stoichiometric conversion factor of 13:0 FAME into 13:0 TAG (0.994); A23:0: peak area of 23:0 internal standard in the chromatogram; m13:0: mass of TAG 13:0 added to the solution (mg).
Reaction efficacy by atmospheric solids analysis probe mass spectrometry
A Xevo TQ-D mass spectrometer (Waters, Massachusetts, USA) with a triple quadrupole mass analyzer, equipped with an ASAP (Waters, Massachusetts, USA) was applied to assess the efficacy of the PM and compare it to the TM of lipid extraction and esterification and transesterification. A capillary tube (100 mm × 1.9 mm) was immersed into a vial containing the sample, placed onto the ASAP probe, and introduced into the ion source chamber. For the 150 500 Da mass scan, a probe temperature ramp of 120-300 °C (gradient of 10 C s-1) was used with a 10-70 V cone ramp (gradient of 0.171 V Da-1). For the 500-1000 Da mass scan, a 10-100 V cone ramp (gradient of 0.171 V Da 1) was used with a probe temperature ramp of 300-600 °C (gradient of 10 °C s-1). ASAP-MS analysis was carried out within 4 min, in positive ion mode, and data was processed using the MassLynx TM software.16
Validation parameters
The validation parameters of the PM were determined following the guidelines of the International Conference on Harmonization.26 The figures of merit used were: precision (interand intra-day), accuracy, linear range, and robustness, obtained with 6 replicates. Relative standard deviation (RSD) was evaluated to estimate the precision of the PM by calculating the repeatability of results on the same day (RSDintra-day) and different days (RSDinter-day). Accuracy was estimated by comparing the results obtained from PM and TM. The linear range was determined by interpolation of the sum of FA obtained by TM concerning the PM. The robustness of the PM was evaluated by varying the temperature of the ultrasonic bath (28.5-31.5 °C) and sample injection volume (1-3 μL).14
Application of the method
The PM was applied to samples of HMliq at different lactation phases, colostrum (HMliqC), mature (HMliqM), transitional (HMliqT), and HMlyoC and HMlyoT to evaluate its applicability using different HM forms and lactation phases.
Statistical analysis
The FA composition of HM samples was acquired in triplicate and expressed as mean values ± standard deviation. The results were subjected to analysis of variance (ANOVA) and values were compared by Tukey’s test at a 95% significance level using the Assistat 7.7 software.27
Results and Discussion
Experimental design
The PM for the direct methylation of HMlyoM was developed and optimized based on existing methods used for evaluating the FA composition of biological fluids.17,19,20,25 In the literature,25 only one study developed and validated a direct method to analyze the FA content in HMliq samples. However, HMliq samples were heated to 100 °C for 60 min. Such high temperatures can easily undergo lipid degradation, including butyric acid (4:0), caproic acid (6:0), caprylic acid (8:0), and capric acid (10:0).7 In contrast, in our study, the PM is performed at room temperature (25 °C) to maintain the integrity of the lipids, avoiding oxidation reactions. In the present study, two base-catalyzed transesterification methods were explored for methylation: KOH/MeOH and HCl/MeOH. The KOH/MeOH has been used in several studies.20,28 This method can be performed at room temperature, requiring a short derivatization time, showing good efficiency in the derivatization process for the FA in triacylglycerols (TAGs).12,28,29 On the other hand, the HCl/MeOH was selected because it gives semi quantitative yields and is simple to operate.12,29 It is comparable to other acid catalysts such as sulfuric acid (H2SO4) and boron trifluoride (BF3), with the advantage of low cost and large availability.12,28,29
Once the independent variables were defined, a rotational central composite design was generated by Design Expert® 7 software,22 and the results obtained for each experimental run are presented in Table 1. The highest rate of FA esterification achieved was in experiment 5 with a FAs sum of 409.5600 mg g-1 of sample. This result was obtained with the use of KOH/MeOH (0.75 mol L-1) and HCl/MeOH (1.5 mol L-1) using equal reaction times for the alkaline and acid reactions. To evaluate the model obtained and the interactions between the factors, the results were submitted to ANOVA and the response surface was generated by the Design Expert® 7 software. Among the models suggested by the software (linear, two-factor interaction (2FI), quadratic, and cubic), the cubic model was selected as being the most appropriate due to its high order of significance, low lack of adjustment, and reasonable agreement between the correlation coefficients proposed for the model. Table 2 presents the ANOVA parameters.
The statistical significance of the factors was evaluated by employing the t-test (Student’s t-distribution) with p-value and F-test (Fischer’s distribution). Values of Prob. > F less than 0.0500 indicate that the terms of the model are significant. In this study, A, D, AE, BC, BD, BE, CD, B2, D2, A2B, A2C, A2D, A2E, and AB2 are significant model terms. The F-value of 24.24 for the model implies the model is significant. There is a 0.04% chance that the F-value of the model could occur due to noise. The “lack of-fit” F-value of 4.34 implies that this term is not significant about the pure error. There is a 9.18% chance that the “lack-of-fit” F-value could occur due to noise. The coefficient of determination (R2) defined was R2 = 0.9906 agrees with the adjusted R2 (0.9494), which signals a good fit between the cubic model and experimental data. The low value of the coefficient of variation (CV: 5.36%), indicates the good reproducibility of the model. “Adequate precision” was applied to measure the signal-to-noise ratio. A ratio greater than 4 is desirable for the PM model. The ratio of 25.36 indicates an adequate signal, which demonstrates that this model can be used to evaluate the PM for HMlyoM.30
The model was adjusted based on actual values of factor functions studied and presented in equation 3. The relationship between predicted, and actual values is illustrated in Figure S1 (SI section). Besides, the predicted response for the dependent variable (maximum intensity) could be obtained via the second-order polynomial equation (equation 3) by multiple regression analysis on the experimental data.
Figure S1 shows that the model is well-adjusted because the actual values are close to the straight line, agreeing with the R2 value. The response surface (Figure S2, SI section) showed a reduction in the FA sum upon decreasing the concentration of HCl/MeOH. The lowest sum of FA was obtained when the lowest concentration of HCl/MeOH was used. A direct correlation between HCl/MeOH concentration and the sum of FAs can be observed on the 3D plot. The positive impact of the acid reaction in the sum of FAs may be because of the broader spectrum of lipid classes (e.g., triacylglycerols (TAGs), diacylglycerols (DAGs), monoacylglycerols (MAGs), and free FAs) that HCl/MeOH enables to derivatize.31
Optimization of the model
The optimization of the PM conditions was performed to prepare the experimental conditions for a fast reaction time and low amount of sample. Therefore, both alkaline and acid reaction times parameters were limited to 20 min and the sample amount parameter was restricted to 240 mg. The Design Expert® 7 software theoretically predicted the optimum parameters as the following: 10 min for both alkaline and acid reaction time; concentrations of 1.5 and 0.75 mol L-1 for HCl/MeOH and KOH/MeOH, respectively; and 100 mg of sample. These conditions should provide a sum of FA 409.5620 mg g-1 of sample.
Assessment of the reaction efficiency by ASAP-MS
The ASAP-MS is an ionization technique for rapid and direct analysis of solids and liquids.32 In this study, ASAP MS was used to evaluate the reaction efficiency of the PM compared with the TM. To date, there has been no detailed investigation of the HM lipid profile using ASAP MS as an analytical technique. However, existing studies on the HM lipid profile,11,15,33 have shown that ion peaks of DAGs and TAGs appear in the region of m/z 500 1000 in the mass spectra. Then, Figures 1 and 2 show the mass spectra of the unesterified compounds (m/z 500-1000) and the esterified compounds (m/z 150 500), respectively by the PM (HMlyoM-PM) and TM (HMlyoM TM). In both methods (PM and TM), DAGs and TAGs (m/z 500-1000) were found as unesterified products, however, the intensities and quantities of peaks were smaller using PM than TM (Figure 1), which shows the relevance of PM.
Mass spectra of the unesterified compounds of HMlyoM by the PM (HMlyoM-PM) and traditional methodology (HMlyoM-TM) in the range of m/z 500-1000.
Mass spectra of the esterified compounds of HMlyoM by the PM (HMlyoM-PM) and traditional methodology (HMlyoM-TM) in the range of m/z 150-500.
The [M]+, [M + H]+, and [M + K]+ ions were identified in the mass spectra of both derivatization methods. In ASAP ionization, the compounds are volatilized using heated steam of nitrogen and submitted to a proton transfer reaction near the corona discharge needle, which leads to the formation of [M + H]+ and [M]+ ions depending on the content of residual water inside the ion source.34,35 Therefore, both ionization can occur inside the ion source. Moreover, [M + K]+ ions are also observed in the mass spectra because both PM and TM use a KOH solution in the alkaline catalysis. Thus, during the ASAP process, potassium is ionized, forming potassium adducts.36
In both derivatization methods, the [M]+ ions were identified as m/z 155, 169, 183, 211, 225, 239, 253, 267, 265, 263, and 293. These ions correspond to the FAME fragments of the respective fatty acids: 10:0, 11:0, 12:0, 14:0, 15:0, 16:0, 17:0, 18:0, 18:1, 18:2, and 20:1. These results are according to the work of Sud et al.,37 which demonstrates that the peaks obtained for ionized FAMEs and FAME fragments previously attached to TAG molecules have distinct m/z ratios. In [M + K]+ form, ions were identified with m/z 169, 197, 225, 253, 279, and 281 corresponding to the FAME fragments of fatty acids 6:0, 8:0, 10:0, 12:0, 14:1, and 14:0, respectively. The most abundant ion peaks present in the mass spectra, m/z 269, 271, 293, 297, and 299 are related to the [M + H]+ form, which corresponds to the FAME fragments of fatty acids 16:1, 16:0, 18:3, 18:1, and 18:0, respectively. These results are according to the literature,11 which shows that 18:1n-9 and 16:0 are the major fatty acids found in HM and reported similar FAMEs composition for HM.33
Assessment of the proposed method by GC-FID
The chromatograms of HMlyoM-TM and HMlyoM PM are illustrated in Figure S3 (SI section). Both chromatograms are similar and exhibited a good level of separation, great resolution, and absence of interferences, indicating that PM has good sensibility and detectability.
Table 3 presents the quantification of FAs for HMlyoM TM and HMlyoM-PM obtained by GC-FID. A total of 35 FAs were identified and quantified in HMlyoM for both methods. The use of GC-MS could aid in identification, as the MS detector provides information about the molecular weight and structure of the analyte. However, the FID was chosen due to its high detectability and selectivity for compounds containing carbon in their composition, such as methyl esters of fatty acids.
Fatty acid quantification for lyophilized human milk in the mature lactation phase by the traditional method of extraction and derivatization compared to the proposed method by gas chromatography with flame ionization detector
However, the sum of FA was higher for PM (409.5620 ± 5.8429 mg g-1 of sample) than TM (277.5035 ± 8.9380 mg g-1 of sample). The results obtained are justified because TM requires an extraction step of the lipid matrix before derivatization, which may lead to errors related to sample manipulation, resulting in a decrease in the amount of lipid. In addition, non-lipid compounds can also be extracted due to the interactions of the solvents. Therefore, non-lipid compounds are not esterified/transesterified and are not considered. This error is minimized in the PM, as the derivatization is performed directly on the sample matrix and quantification involves the mass of the sample. Then, the results obtained using PM are not influenced by extraction errors.
Validation of the method
The accuracy values of PM ranged from 99.87 to 102.16%, below the values defined in the guidelines.26 The RSDintra-day (1.34-4.03%) and RSDinter-day (2.08 5.16%) showed that the PM presents good precision. The correlation between the sum of FA obtained by PM and TM allowed the evaluation of linearity. The coefficient of determination was R2 = 0.9996, indicating that PM is well correlated with TM, within the linear range of 3 to 38% of the total lipids in the sample.
The robustness of the PM was achieved by changing the temperature of the ultrasonic bath (29 to 32 °C) and the injection volume (1 to 3 µL). Small variations in injection volume did not significantly change the results, remaining within the coefficient of variation range (5.36%). However, the variation in the temperature of the ultrasonic bath significantly affected the results, leading to decreased accuracy. The recovery experiments were performed by adding TAG 13:0 into HMlyoM samples. Recovery values for PM ranged between 99 to 100%, which is considered acceptable, demonstrating that the PM is adequate.
Application of the method
Table 4 shows the results of the FA quantification of HMliqC, HMliqT, HMliqM, HMlyoC, and HMlyoT by PM. The sum of FA obtained by PM was 373.4417 ± 0.0001 mg g-1 (HMlyoC), 376.1192 ± 0.0001 mg g-1 (HMlyoT), 35.4857 ± 0.0001 mg g-1 (HMliqC), 38.8711 ± 0.0001 mg g-1 (HMliqT), and 42.9602 ± 0.0001 mg g-1 (HMliqM). The results have been shown in absolute quantity (mg g-1 of sample) because it provides much more information about the absolute FA content in HM. However, very few studies have presented absolute FA concentrations in HM, then it is difficult to compare the results from this study.
Fatty acid quantification of lyophilized human milk in the colostrum and transitional lactation phases, and liquid human milk in all lactation phases (colostrum, transitional, and mature) by the proposed method
Regarding HMliq and HMlyo, an 8-fold decrease in the sum of FA was observed in HMliq. For example, HMlyoC and HMliqC presented the sum of FA of 373.4417 ± 0.0001 and 35.485 ± 0.0001, respectively. This high sum of FA in HMlyo is related to the lyophilization process, which is used to remove the water from the sample, so concentrating its compounds, such as FAs.38,39 Another fact is that the HMliq is composed of 85% water;40 thus, the water content HMliq may affect the performance of the derivatization, producing undesirable reactions, such as saponification,28 which may decrease the detected quantity of FAs.
In addition, note that there is a variation of FA concentration between HM at different lactation stages, which is common according to previous research.2,41,42
Conclusions
In the present study, the method developed, optimized, and validated can be used to quantify the FA in HMlyo. The proposed method requires a low volume of solvents and a low amount of sample, it is less susceptible to experimental errors due to decreased sample manipulation and experimental steps and provides a fast sample preparation procedure. The proposed method is robust, efficient, and has good accuracy compared to traditional methodologies. The application of the method demonstrated that there is a variation of FA concentration between HM at different lactation stages and between HMliq and HMlyo. This type of information is important to evaluate the intake and needs of newborns, and the proposed method can assess it in a very short time compared with traditional methods.
Supplementary Information
Supplementary data with the experimental conditions generated by experimental design, linear regression graph, 3D plot of the response surface, and chromatograms are available free of charge at http://jbcs.sbq.org.br as PDF file. PDF
Acknowledgments
This work was supported by the Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES), Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq), Programa Pesquisa para o SUS (PPSUS) and Fundação Araucária with financial support and fellowships.
References
-
1 World Health Organization (WHO); Global Strategy for Infant and Young Child Feeding; WHO: Geneva, 2003. [Link] accessed April 2024
» Link -
2 Floris, L. M.; Stahl, B.; Berkeveld, M. A.; Teller, I. C.; Prostaglandins, Leukotrienes Essent. Fatty Acids 2020, 156, 102023. [Crossref]
» Crossref -
3 Jagodic, M.; Snoj Tratnik, J.; Potočnik, D.; Mazej, D.; Ogrinc, N.; Horvat, M.; Food Chem. Toxicol. 2020, 141, 111299. [Crossref]
» Crossref -
4 Roche, M. L.; Creed-Kanashiro, H. M.; Tuesta, I.; Kuhnlein, H. V.; Matern. Child Nutr. 2011, 7, 284. [Crossref]
» Crossref -
5 Wei, W.; Jin, Q.; Wang, X.; Prog. Lipid Res. 2019, 74, 69. [Crossref]
» Crossref -
6 Manin, L.; Rydlewski, A.; Galuch, M.; Pizzo, J.; Zappielo, C.; Senes, C.; Santos, O. O.; Visentainer, J. V.; J. Braz. Chem. Soc. 2019, 30, 1579. [Crossref]
» Crossref -
7 Rydlewski, A. A.; Pizzo, J. S.; Manin, L. P.; Zappielo, C. D.; Galuch, M. B.; Santos, O. O.; Visentainer, J. V.; Rev. Virtual Quimica 2020, 12, 155. [Crossref]
» Crossref -
8 Lauritzen, L.; Fewtrell, M.; Agostoni, C.; Pediatr. Res. 2015, 77, 263. [Crossref]
» Crossref -
9 George, A. D.; Gay, M. C. L.; Wlodek, M. E.; Murray, K.; Geddes, D. T.; Nutrients 2021, 13, 4183. [Crossref]
» Crossref -
10 Chen, Y. J.; Zhou, X. H.; Han, B.; Li, S. M.; Xu, T.; Yi, H. X.; Liu, P.; Zhang, L. W.; Li, Y. Y.; Jiang, S. L.; Pan, J. C.; Ma, C. H.; Wang, B. C.; Food Res. Int. 2020, 133, 109196. [Crossref]
» Crossref -
11 Rydlewski, A.; Silva, P.; Manin, L.; Tavares, C.; Paula, M.; Figueiredo, I.; Neia, V.; Santos, O. O.; Visentainer, J. V.; J. Braz. Chem. Soc. 2019, 30, 1063. [Crossref]
» Crossref -
12 Hewavitharana, G. G.; Perera, D. N.; Navaratne, S. B.; Wickramasinghe, I.; Arabian J. Chem. 2020, 13, 6865. [Crossref]
» Crossref -
13 Folch, J.; Lees, M.; Stanley, G. H. S.; J. Biol. Chem. 1957, 226, 497. [Crossref]
» Crossref - 14 Collins, C. H.; Braga, C. G. L.; Bonato, P. S.; Fundamentos de Cromatografia, 1st ed.; Editora da Unicamp: Campinas, 2006.
-
15 Dai, X.; Yuan, T.; Zhang, X.; Zhou, Q.; Bi, H.; Yu, R.; Wei, W.; Wang, X.; Food Funct. 2020, 11, 1869. [Crossref]
» Crossref -
16 Figueiredo, I. L.; Claus, T.; Santos Jr., O. O.; Almeida, V. C.; Magon, T.; Visentainer, J. V.; J. Chromatogr. A 2016, 1456, 235. [Crossref]
» Crossref -
17 Piccioli, A.; Santos, P.; da Silveira, R.; Bonafe, E.; Visentainer, J. V.; Santos, O. O.; J. Braz. Chem. Soc. 2019, 30, 1350. [Crossref]
» Crossref -
18 Park, P.; Goins, R. E.; J. Food Sci. 1994, 59, 1262. [Crossref]
» Crossref -
19 Liu, Z.; Ezernieks, V.; Rochfort, S.; Cocks, B.; Food Chem. 2018, 261, 210. [Crossref]
» Crossref -
20 Liu, Z.; Wang, J.; Li, C.; Rochfort, S.; Food Chem. 2020, 315, 126281. [Crossref]
» Crossref -
21 International Organization for Standardization (ISO); ISO 12966: Animal and Vegetable Fats and Oils - Gas Chromatography of Fatty Acid Methyl Esters Part 2: Preparation of Methyl Esters of Fatty Acids, ISO: Geneva, 2017. [Link] accessed in April 2024
» Link - 22 Design Expert, version 7.0; Stat-Ease, Minneapolis, MN, USA, 2007.
-
23 Leonzio, G.; Zondervan, E.; Comput.-Aided Chem. Eng. 2019, 46, 151. [Crossref]
» Crossref - 24 Visentainer, J. V.; Franco, M. R. B.; Ácidos Graxos em Óleos e Gorduras: Identificação e Quantificação, 2nd ed.; Eduem: Maringá, 2012.
-
25 Cruz-Hernandez, C.; Goeuriot, S.; Giuffrida, F.; Thakkar, S. K.; Destaillats, F.; J. Chromatogr. A 2013, 1284, 174. [Crossref]
» Crossref -
26 International Conference on Harmonization (ICH); Guideline Q2(R1) Validation of Analytical Procedures: Text and Methodology, ICH: Stanford, 2005. [Link] accessed April 2024
» Link - 27 Silva, F. A. S.; The ASSISTAT Software: Statistical Assistance; Universidade Federal de Campina Grande, Brazil, 1996.
-
28 Milinsk, M. C.; Matsushita, M.; Visentainer, J. V.; Oliveira, C. C.; Souza, N. E.; J. Braz. Chem. Soc. 2008, 19, 1475. [Crossref]
» Crossref -
29 Chiu, H. H.; Kuo, C. H.; J. Food Drug Anal. 2020, 28, 60. [Crossref]
» Crossref -
30 Chiavelli, L. U. R.; Godoy, A. C.; da Silveira, R.; Santos, P. D. S.; Lopes, T. A. M.; Santos, O. O.; Visentainer, J. V.; Food Anal. Methods 2020, 13, 166. [Crossref]
» Crossref -
31 Cruz-Hernandez, C.; Destaillats, F. In Gas Chromatography; Poole, C. F., ed.; Elsevier: Amsterdam, 2021, ch. 27. [Crossref]
» Crossref -
32 Smith, M. J. P.; Cameron, N. R.; Mosely, J. A.; Analyst 2012, 137, 4524. [Crossref]
» Crossref -
33 Rydlewski, A. A.; Manin, L. P.; Pizzo, J. S.; Silva, P. D.; da Silveira, R.; Tavares, C. B. G.; de Paula, M.; Pereira, O.; Santos, O. O.; Visentainer, J. V.; J. Food Compos. Anal. 2021, 100, 103797. [Crossref]
» Crossref -
34 Petucci, C.; Diffendal, J.; J. Mass Spectrom. 2008, 43, 1565. [Crossref]
» Crossref -
35 Tose, L. V.; Murgu, M.; Vaz, B. G.; Romão, W.; J. Am. Soc. Mass Spectrom. 2017, 28, 2401. [Crossref]
» Crossref -
36 Krejčí, P.; Cechová, M. Z.; Nádvorníková, J.; Barták, P.; Kobrlová, L.; Balarynová, J.; Smýkal, P.; Bednář, P.; Talanta 2022, 242, 123303. [Crossref]
» Crossref -
37 Sud, M.; Fahy, E.; Cotter, D.; Brown, A.; Dennis, E. A.; Glass, C. K.; Merrill, A. H.; Murphy, R. C.; Raetz, C. R. H.; Russell, D. W.; Subramaniam, S.; Nucleic Acids Res. 2007, 35, D527. [Crossref]
» Crossref -
38 Pisano, R.; Arsiccio, A.; Capozzi, L. C.; Trout, B. L.; Eur. J. Pharm. Biopharm. 2019, 142, 265. [Crossref]
» Crossref -
39 Morais, A. R. V.; Alencar, E. N.; Xavier Júnior, F. H.; de Oliveira, C. M.; Marcelino, H. R.; Barratt, G.; Fessi, H.; do Egito, E. S. T.; Elaissari, A.; Int. J. Pharm. 2016, 503, 102. [Crossref]
» Crossref -
40 Meng, F.; Uniacke-Lowe, T.; Ryan, A. C.; Kelly, A. L.; Trends Food Sci. Technol. 2021, 112, 608. [Crossref]
» Crossref -
41 Jiang, J.; Wu, K.; Yu, Z.; Ren, Y.; Zhao, Y.; Jiang, Y.; Xu, X.; Li, W.; Jin, Y.; Yuan, J.; Li, D.; Food Funct. 2016, 7, 3154. [Crossref]
» Crossref -
42 van de Heijning, B. J. M.; Stahl, B.; Schaart, M. W.; van der Beek, E. M.; Rings, E. H. H. M.; Mearin, M. L.; Adv. Pediatr. Res. 2017, 4, 16. [Link] accessed April 2024
» Link
Edited by
-
Editor handled this article: Andrea R. Chaves (Associate)
Publication Dates
-
Publication in this collection
10 June 2024 -
Date of issue
2025
History
-
Received
26 Jan 2024 -
Accepted
14 May 2024